Thymogen

Research Phase

Thymogen (Glu-Trp Dipeptide)

Aliases
Glu-Trp, L-glutamyl-L-tryptophan
Administration
Intramuscular injection, Intranasal

Overview

Thymogen is a synthetic dipeptide (just two amino acids, glutamic acid and tryptophan) developed as a simplified alternative to thymus-extract peptides like Thymalin, based on identifying the smallest active sequence responsible for their immune effects. Like other Khavinson-tradition bioregulatory peptides, it is studied in Russian clinical research for supporting immune function and is available in both injectable and intranasal forms.

Treatments studied

Treatment categories

Immune system decline (age-related)

A simplified, synthetic alternative to Thymalin, studied for the same age-related immune support purpose using a minimal two-amino-acid sequence.

Immune system strengthening

Supports T-cell differentiation similar to Thymalin, with the practical advantage of being available in an intranasal form.